Stability of Tranexamic Acid Mouth Rinse
Download in electronic PDF format for $75
Abstract: Tranexamic acid is an antifibrinolytic agent that inhibits the conversion of plasminogen to plasmin and is used to treat fibrinolytic hemorrhages. Tranexamic acid mouth rinse was compounded using active pharmaceutical ingredient powder or commercial tablets. The bitter taste was masked by using either cherry-vanilla or peppermint and mint flavoring and aspartame. Tranexamic acid mouth rinse solutions were stored at either 23°C or 5°C in polyethylene terephthalate bottles for 31 days. Stability was accessed using a stability-indicating high-performance liquid chromatographic method. Color, clarity, caking, resuspendability, and pH were also monitored. All solutions remained above 97.2% of the initial concentrations after 31 days storage at either 23°C or 5°C and protected from light. The powder-based solutions remained clear, and no color change was observed. However, some of the tablet formulations stored at 23°C turned yellow to dark brown after 21 days. Insoluble material from the tablet formulations settled out but was easy to resuspend with no caking. The pH of the tranexamic acid mouth rinse solutions changed slightly over the course of the study. All tranexamic acid mouth rinse solutions were chemically stable for 31 days when stored at either 23°C or 5°C and protected from light.
Related Keywords:
Ronald F. Donnelly, MSc (Chem), BSc (Pharm), tranexamic acid, formulations, antifibrinolutic agent, plasminogen, plasmin, fibrinolysis, fibrinolytic hemorrhage, oral bleeding, dental procedures, shelf life, mouth rinse, flavoring, chemical stability
Related Categories:
FORMULATIONS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, DOSAGE FORMS/DRUG CARRIERS, HEMOSTASIS, BLEEDING, ANTICOAGULATION
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Stability of Tranexamic Acid Mouth Rinse
Donnelly Ronald F
|
Sep/Oct 2018
Pg. 412-416
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
Tranexamic Acid 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 417
|
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 410
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Stability of Venlafaxine Immediate-Release Suspensions
Donnelly Ronald F, Wong Keith, Goddard Rob, Johanson Christel
|
Jan/Feb 2011
Pg. 81-84
|
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers
McCluskey Susan V, Sztajnkrycer Matthew D, Jenkins Donald A, Zietlow Scott P, Berns Kathleen S, Park Myung S
|
Sep/Oct 2014
Pg. 432-437
|
Hypochlorous Acid 0.01% Oral Rinse
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 147
|
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid
Gupta Vishnu D, Ling Jie
|
May/Jun 2001
Pg. 232-233
|
Aminocaproic Acid 250-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 404
|
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Zhang Yan-ping, Trissel Lawrence A
|
Mar/Apr 1997
Pg. 132-134
|
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids
de Villiers Melgardt M, Narsai Kirti, van der Watt Jakkie G
|
Jan/Feb 2000
Pg. 72-75
|
Chemical Facial Peel Formulations: an Overview
Levine Phillip J
|
Sep/Oct 1999
Pg. 375-377
|
Aminocaproic Acid 250-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 415
|
Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing
Song Guiyun, Banov Daniel, Bassani August S
|
Jan/Feb 2018
Pg. 60-65
|
Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
|
Nov/Dec 2021
Pg. 523-527
|
Featured Excipient: Flavor Enhancing Agents
Allen Loyd V Jr
|
Jan/Feb 2003
Pg. 48-50
|
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
|
Nov/Dec 2004
Pg. 458-460
|
Ketoprofen 100-mg/5-mL Mouth Rinse
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 68
|
Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats
Nani Marcel, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini
|
Mar/Apr 2018
Pg. 154-163
|
Return to Top |